The epithelial to mesenchymal transition in pancreatic cancer: A systematic review

Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]
Mircea BeuranSorin Hostiuc

Abstract

The present article summarizes and analyzes the current knowledge about the role of the epithelial to mesenchymal transition (EMT) in the systemic invasiveness of pancreatic cancer. An electronic search of PubMed/MEDLINE, EMBASE, and the Web of Science was used to identify relevant original articles and reviews. The EMT represents a key step during normal embryogenesis. However, increasing evidence reveals its essential role in the local progression and metastasis of pancreatic cancer. Areas of interest are the cross-linking between cells undergoing the EMT and pancreatic cancer stem cells, and the correlation between the EMT and chemoresistance to standard therapies. During carcinogenesis, malignant pancreatic cells at the primary site acquire the ability to undergo the EMT, a transformation associated with increased mobility. The reverse process at secondary sites, the mesenchymal to epithelial transition (MET), has devastating consequences, allowing neoplastic epithelial cells to invade surrounding tissues and spread to distant sites. Consequences of the EMT are the loss of E-cadherin expression and the acquisition of mesenchymal markers including fibronectin or vimentin. Detailed knowledge of the molecular processes underly...Continue Reading

References

Aug 30, 2001·Proceedings of the National Academy of Sciences of the United States of America·T BrabletzT Kirchner
Jul 4, 2002·Cell Biology International·Kwonseop KimElizabeth D Hay
Aug 22, 2002·Nature Reviews. Cancer·Jean Paul Thiery
Nov 19, 2003·Mechanisms of Development·David Shook, Ray Keller
Dec 4, 2003·Current Opinion in Cell Biology·Jean Paul Thiery
Dec 18, 2003·The Journal of Clinical Investigation·Raghu Kalluri, Eric G Neilson
Mar 31, 2004·Lancet·Donghui LiJames L Abbruzzese
May 4, 2004·Nature Reviews. Cancer·Andreas GschwindAxel Ullrich
May 25, 2004·Genes & Development·Sonia VegaM Angela Nieto
Jun 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sanae NakajimaMasayuki Imamura
Dec 2, 2004·Nature Reviews. Drug Discovery·Jonathan M YinglingJ Scott Sawyer
Aug 16, 2005·Current Opinion in Cell Biology·Margit A HuberHartmut Beug
Mar 25, 2006·Nature Reviews. Cancer·Aurora Esquela-Kerscher, Frank J Slack
May 26, 2006·Nature·Gerhard Christofori
Jan 2, 2007·Biochemical and Biophysical Research Communications·Yukinari TakaoHiroshi Koide
Jan 20, 2007·International Journal of Cancer. Journal International Du Cancer·Kenoki OhuchidaMasao Tanaka
Feb 7, 2007·Cancer Research·Chenwei LiDiane M Simeone
Aug 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Birgit HotzHubert G Hotz
Sep 11, 2007·The International Journal of Biochemistry & Cell Biology·Marcello Guarino
Sep 15, 2007·Journal of Cellular Biochemistry·Nancy Gavert, Avri Ben-Ze'ev
Oct 3, 2007·Annals of Surgical Oncology·Ami N ShahGary E Gallick
Dec 11, 2007·The Journal of Pathology·D MizrakM R Alison
Mar 18, 2008·Seminars in Cell & Developmental Biology·Buzz BaumMargaret P Quinlan
May 3, 2008·Cancer Research·I Bernard Weinstein, Andrew Joe
Jun 10, 2008·Developmental Cell·Jing Yang, Robert A Weinberg
Jul 9, 2008·World Journal of Gastroenterology : WJG·Ammar NatalwalaChris Tselepis
Sep 4, 2008·Pancreas·Justin M M CatesCandice C Black
Nov 26, 2008·Oncogene·G Moreno-BuenoA Cano

❮ Previous
Next ❯

Citations

Oct 9, 2015·Journal of Translational Medicine·Xiao-Bin CuiFeng Li
Apr 7, 2016·Stem Cells and Development·Floryne O BuishandJan A Mol
Jul 26, 2016·Frontiers in Oncology·Leonardo Marques da FonsecaMárcia Alves Marques Capella
Mar 31, 2016·PloS One·Oliver H WangAnirban Maitra
Apr 2, 2017·Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·Masaki MichishitaKimimasa Takahashi
Jun 3, 2017·Experimental Cell Research·Nicoletta GaglianoPatrizia Procacci
Mar 31, 2017·Biomedical Microdevices·Qihui PuLisa A DeLouise
Mar 29, 2018·Journal of Experimental & Clinical Cancer Research : CR·Zhengdong JiangJiguang Ma
Jun 16, 2018·Molecular Cancer·Demi S Houg, Maarten F Bijlsma
Feb 15, 2019·International Journal of Molecular Sciences·Daniel H F HuiChristopher J Ong
Nov 21, 2016·Cellular and Molecular Neurobiology·Shunjun XiongXiaofang Zhang
Oct 5, 2016·Experimental and Therapeutic Medicine·Hongyi TanPinhua Pan
Nov 30, 2018·World Journal of Gastroenterology : WJG·Wen-Yan XuXian-Jun Yu
Dec 10, 2015·International Journal of Oncology·Jian LiJingping Liu
Dec 14, 2016·BioMed Research International·Hang YinHailin Liu
Aug 6, 2017·Naunyn-Schmiedeberg's Archives of Pharmacology·Barbara MayerAlexandr V Bazhin
Apr 26, 2020·Cells·Michele Sommariva, Nicoletta Gagliano
Dec 8, 2016·Cancer Research·Tiansuo ZhaoJihui Hao
Jan 6, 2021·Journal of Cellular Physiology·Qi YanJian Du
Feb 12, 2021·International Journal of Molecular Sciences·Arjanneke F van de MerbelGabri van der Pluijm

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.